Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy

NCT07423390 is registered in ClinicalTrials.gov with Qinghai Red Cross Hospital as lead sponsor.

NCT NCT07423390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07423390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
Lead sponsor
Qinghai Red Cross Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
February 24, 2026
Completion date
May 31, 2029
Enrollment
326 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy due to chemotherapy, peripheral neuropathy, chemotherapy-induced